SCHEMBL22012047

SCHEMBL22012047

c1ccc(-c2ccc3c4c5oc6ccccc6c5c5c(ccc6oc7ccccc7c65)c4n(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.34
ALDH1A1 P00352 5/20 0.34
TSHR P16473 4/20 0.34
HPGD P15428 2/20 0.34
PLA2G2A P14555 1/20 0.33
PLA2G4A P47712 1/20 0.33
LMNA P02545 5/20 0.32
KDM4E B2RXH2 3/20 0.32
POLB P06746 3/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
GAA P10253 2/20 0.32
USP2 O75604 1/20 0.31
HTT P42858 1/20 0.31
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011564 0.94 MAPT (0.33) MAPTALDH1A1TSHRHPGDPLA2G2A
SCHEMBL22011566 0.93 MAPT (0.34) MAPTALDH1A1TSHRHPGDPLA2G2A
SCHEMBL22011560 0.92 MAPT (0.32) MAPTALDH1A1TSHRHPGDPLA2G2A
SCHEMBL22011563 0.92 MAPT (0.36) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL22011561 0.91 MAPT (0.34) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL22011567 0.88 AHR (0.32) MAPTALDH1A1HPGDKDM4EKMT2A
SCHEMBL18868046 0.87 PLA2G2A (0.36) MAPTALDH1A1TSHRHPGDPLA2G2A
SCHEMBL22011568 0.86 MAPT (0.33) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL22011976 0.84 MAPT (0.37) MAPTALDH1A1TSHRHPGDLMNA
SCHEMBL22011569 0.84 MAPT (0.34) MAPTALDH1A1TSHRHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 EP disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 MAPT 4261/4885ALDH1A1 1119/4885TSHR 3272/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 MAPT 4261/4885ALDH1A1 1119/4885TSHR 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.